PHRI NEWS & EVENTS
WHYY (PBS & NPR) reports on the SARS-CoV-2 variants assay developed at PHRI. Read the story at whyy.org
Ryan Dikdan, Salvatore Marras and Sanjay Tyagi developed a rapid (less than 90 minutes) molecular beacon probe based multiplex RT-PCR assay that detects the current Variants of Concern of SARS-CoV-2, including Alpha, Beta, Gamma, Delta, and Omicron. Their work is published in the March issue of the Journal of Molecular Diagnostics and can be accessed on www.jmdjournal.org
Maria Laura Gennaro has been nominated Inaugural Chair of the Microbiology Committee of RECOVER, a $470-million initiative funded by the National Institutes of Health to learn why some people develop “Long COVID”, i.e., they have prolonged symptoms or develop new or returning symptoms after the initial (acute) phase of infection with SARS-CoV-2, the virus that causes COVID-19 (www.recovercovid.org). The Microbiology Committee chaired by Dr. Gennaro will be one of six Pathobiology Multi-Disciplinary Task Force Committees coordinated by the RECOVER Clinical Science Core. For additional information on Rutgers participation to the RECOVER initiative, visit www.newswise.com.
Padmapriya Banada and David Alland’s group developed a screening test for Omicron and other SARS-CoV-2 variants and submitted the test for clinical use on patients. For more details, visit www.research.rutgers.edu.
There are postdoctoral and staff opportunities at PHRI. In addition, Faculty positions at the level of Assistant Professor are available. For details, visit Open Positions.